Physician

Brendan A Mielke, MD

According to 2025 Medicare claims, Brendan Mielke, MD (NPI: 1265425532) practices nephrology in the Coeur d'Alene, ID market, with the plurality of this provider's patient population coming from Kootenai, ID. This provider's primary affiliated billing organization is KOOTENAI HEALTH, INC. (NPI: 1174661151; TIN: 820380784) and primary practice location at 83814-2698. Mielke is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), participating under the MSSP model.

Mielke's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 465 traditional Medicare patients, billed 2,184 HCPCS/CPT codes, and received $195,426 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,870 prescription claims across 409 beneficiaries totaling $590,313 in drug costs, led by Jardiance (Empagliflozin). DME data shows 517 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $291,347 to $590,313. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $5,302 and ending at $1,023.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	444	4,483	$238,430
2016	483	4,717	$245,078
2017	538	3,234	$234,637
2018	517	2,322	$223,691
2019	595	2,502	$249,913
2020	562	2,418	$236,896
2021	535	2,148	$238,182
2022	470	1,862	$220,599
2023	490	1,830	$215,577
2024	465	2,184	$195,426

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	285	4,568	$291,347
2016	288	4,173	$301,334
2017	273	4,029	$369,993
2018	282	3,289	$239,106
2019	311	3,229	$292,488
2020	340	3,674	$289,092
2021	359	3,852	$364,986
2022	385	3,896	$348,346
2023	401	3,831	$452,646
2024	409	3,870	$590,313

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	76	927	$64,644
2016	70	904	$54,802
2017	65	897	$52,366
2018	77	766	$46,640
2019	73	890	$54,131
2020	86	910	$59,439
2021	73	968	$63,231
2022	49	776	$42,596
2023	50	721	$41,653
2024	11	517	$35,483

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	74	78	$122
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	68	220	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	308	635	$73
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	65	144	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	295	603	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	219	11,511	$211,877
Ozempic	Semaglutide	56	1,932	$57,843
Eliquis	Apixaban	29	2,450	$43,340
Velphoro	Sucroferric Oxyhydroxide	11	450	$35,913
Entresto	Sacubitril/Valsartan	33	1,650	$35,648

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	18	$26,867
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	140	$2,258
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	11	102	$1,750
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	72	$1,506
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	107	$1,428

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Brendan A. Mielke, MD?

Tedicare shows public-source Medicare data for Brendan A. Mielke, MD (NPI 1265425532), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brendan A. Mielke, MD have ACO affiliation data?

Brendan A. Mielke, MD is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621).

What billing organization is linked to Brendan A. Mielke, MD?

Brendan A. Mielke, MD is linked to KOOTENAI HEALTH, INC. (billing NPI 1174661151) in the available physician profile data.

Does Brendan A. Mielke, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.